Malignant Pleural Mesothelioma
84
7
10
48
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
13 trials with published results (15%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.1%
6 terminated out of 84 trials
88.9%
+2.4% vs benchmark
4%
3 trials in Phase 3/4
27%
13 of 48 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 48 completed trials
Clinical Trials (84)
Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology
Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma
A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma
Short Neoadjuvant Hemithoracic IMRT for MPM
Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)
The IMmunotherapy Pleural 5-ALA PDT
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
APG-2449 in Patients With Advanced Solid Tumors
Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma
Autologous Dendritic Cell Vaccination in Mesothelioma
Hemithoracic Arc Radiotherapy Post Pleural Decortication